Aberrant resting-state co-activation network dynamics in major depressive disorder

Area of Science:

• Neuroscience
• Psychiatry
• Medical Imaging

Background:

• Major depressive disorder (MDD) is a widespread and debilitating condition linked to brain network dysfunction.
• Static functional connectivity measures are insufficient to capture the complex, time-varying nature of brain activity in MDD.
• Understanding the dynamic interactions between brain networks in MDD is crucial for developing objective diagnostic tools.

Purpose of the Study:

• To investigate the spatial-temporal dynamics of brain functional networks in individuals with MDD.
• To determine if dynamic neuroimaging properties can reliably distinguish MDD patients from healthy controls.
• To explore the neural mechanisms underlying MDD through dynamic network analysis.

Main Methods:

• Utilized resting-state functional magnetic resonance imaging (fMRI) data from a large cohort (221 MDD patients, 215 healthy controls).
• Applied co-activation pattern analysis to examine spatial-temporal dynamics of brain networks.
• Employed support vector machine (SVM) for individual diagnosis based on dynamic metrics.

Main Results:

• MDD patients exhibited altered dynamic properties (dwell time, occurrence rate, transition probability, entropy) in transient networks like the subcortical network (SCN) and default mode network (DMN).
• Specific dynamic network trajectories, particularly towards the deactivated DMN-Attention Network (ATN), were more frequent in MDD patients.
• SVM achieved high accuracy (84.69% for MDD, 76.77% for first-episode drug-naïve MDD, 88.10% for recurrent MDD) in discriminating patient subgroups from controls.

Conclusions:

• MDD is characterized by significant aberrant dynamic fluctuations within brain networks.
• Dynamic functional properties of the brain offer a promising avenue for objective diagnosis and understanding MDD's neural underpinnings.
• These findings highlight the importance of considering brain network dynamics in the study and treatment of major depressive disorder.